PEI buy-back targets wart-affected potato fields

Jun 17, 2025

The provincial government has introduced the PEI Index Field Buy-Back Program, aimed at purchasing designated potato wart index fields from agricultural producers in Canada. This initiative aligns with commitments outlined in the 2025 Speech from the Throne.

The program seeks to augment current investments and measures by setting up a fund for acquiring farmland marked as index fields. Acquired properties will contribute to preserving seven per cent of Prince Edward Island’s land.

Deputy Premier and Minister of Agriculture Bloyce Thompson stated, "Supporting our producers through this challenging experience has been a main priority for our government, and this buy-back program not only supports affected producers, but also strengthens our entire industry moving forward."

The exploration of purchasing index fields has been extensive, aligning with the new National Potato Wart Response Plan to facilitate industry-wide benefits amidst critical trade dynamics.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.